Unit 20 medical physics techniques completemrrayner
This document outlines a unit on medical physics techniques for a diploma in applied science program. The unit aims to develop learners' understanding of fundamental physics concepts behind medical imaging technologies like x-rays, ultrasounds, MRI, and radiotherapy. It also covers the importance of radiation safety. The unit introduces learners to established medical physics practices and provides a basic introduction to MRI theory. Learners will study atomic structure, ionizing radiation, ultrasounds, radiopharmaceuticals, MRI principles, and radiation safety for radiotherapy treatment of cancer. The document provides learning outcomes and outlines tasks for learners to complete assessments involving producing diagrams, graphs, explanations, and evaluations on various topics.
Domino's Pizza announced third quarter 2009 financial results, with net income up 76.6% year-over-year driven by gains from extinguishing debt, improved operating margins, lower interest expenses, and international store growth. Diluted EPS was $0.31, up from $0.17 in the prior year. Same store sales were flat in the US while growing 2.7% internationally. The company repurchased $71.8 million of debt during the quarter and $140 million year-to-date, realizing pre-tax gains.
- Fastenal Company reported financial results for Q3 2009, with net sales down 21.7% and net earnings down 34.7% from Q3 2008. For the first nine months of 2009, net sales were down 19% and net earnings down 35.6% compared to the same period in 2008.
- The weakened economy continues to negatively impact Fastenal's business, particularly sales to manufacturing and non-residential construction customers. However, steps taken through the "pathway to profit" initiative have helped stabilize costs.
- Fastenal opened 45 new stores in the first nine months of 2009, increased its dividends, and generated strong operating cash flow despite economic challenges.
Q3 2009 Earning Report of Royal Philips Electronicsinvestorrelation
- Philips reported an 11% decline in comparable sales for Q3 2009, driven by declines in Consumer Lifestyle and Lighting. EBITA margins improved due to cost reductions.
- Healthcare sales grew 1% in Q3, with double-digit growth in emerging markets offsetting declines in the US. Emerging markets now represent 42% of Healthcare sales.
- Emerging markets sales declined 11% in Q3 but grew 11% over the last twelve months, reflecting Philips' strategic focus on expanding in these high-growth regions.
HP reported financial results for the third quarter of fiscal year 2009. Revenue declined 2% year-over-year to $27.5 billion but was up 4% excluding currency effects. Non-GAAP earnings per share increased 6% to $0.91. Cash flow from operations was strong at $3.9 billion, up 15% over the prior year. The company saw increased stability in the US market and double-digit growth in China. Integration of the EDS acquisition is ahead of plan and expected to realize significant cost synergies. HP will continue investing in strategic growth areas like data centers, digital printing, and mobility.
Adobe announced it will acquire Omniture for $1.8 billion to combine Adobe's content creation tools with Omniture's analytics and optimization technologies. The acquisition will allow customers to optimize content engagement and advertising effectiveness across digital platforms. Omniture will become a new business unit within Adobe led by its current CEO. The deal is expected to close in the fourth quarter of 2009 and be accretive to Adobe's earnings in 2010.
IBM's strategy focuses on shifting to higher value segments of the IT industry through global integration, productivity improvements, and investing in growth markets and technologies. This transformation has driven margin expansion and allowed IBM to invest in the future while providing returns to shareholders. IBM is well ahead of its goal to achieve $10-11 EPS by 2010 through revenue growth, continued margin gains, and share repurchases. The company will focus on growth markets, acquisitions, technology leadership, and new initiatives to sustain long-term performance.
Abbott: 2009 Annual Shareholders Meeting Remarks And Presentationsinvestorrelation
Miles White, Chairman and CEO of Abbott, presented at the company's annual shareholders meeting. He summarized Abbott's strong financial performance in 2008, with double-digit sales and earnings growth despite economic challenges. Abbott experienced growth across all major businesses - medical devices, nutrition, diagnostics, and pharmaceuticals. White highlighted several new product launches that contributed to growth and discussed Abbott's leadership positions in various health care markets. He expressed confidence in Abbott's ability to meet financial goals for 2009 and emphasized the company's diversity and strength compared to peers in withstanding economic downturns.
Unit 20 medical physics techniques completemrrayner
This document outlines a unit on medical physics techniques for a diploma in applied science program. The unit aims to develop learners' understanding of fundamental physics concepts behind medical imaging technologies like x-rays, ultrasounds, MRI, and radiotherapy. It also covers the importance of radiation safety. The unit introduces learners to established medical physics practices and provides a basic introduction to MRI theory. Learners will study atomic structure, ionizing radiation, ultrasounds, radiopharmaceuticals, MRI principles, and radiation safety for radiotherapy treatment of cancer. The document provides learning outcomes and outlines tasks for learners to complete assessments involving producing diagrams, graphs, explanations, and evaluations on various topics.
Domino's Pizza announced third quarter 2009 financial results, with net income up 76.6% year-over-year driven by gains from extinguishing debt, improved operating margins, lower interest expenses, and international store growth. Diluted EPS was $0.31, up from $0.17 in the prior year. Same store sales were flat in the US while growing 2.7% internationally. The company repurchased $71.8 million of debt during the quarter and $140 million year-to-date, realizing pre-tax gains.
- Fastenal Company reported financial results for Q3 2009, with net sales down 21.7% and net earnings down 34.7% from Q3 2008. For the first nine months of 2009, net sales were down 19% and net earnings down 35.6% compared to the same period in 2008.
- The weakened economy continues to negatively impact Fastenal's business, particularly sales to manufacturing and non-residential construction customers. However, steps taken through the "pathway to profit" initiative have helped stabilize costs.
- Fastenal opened 45 new stores in the first nine months of 2009, increased its dividends, and generated strong operating cash flow despite economic challenges.
Q3 2009 Earning Report of Royal Philips Electronicsinvestorrelation
- Philips reported an 11% decline in comparable sales for Q3 2009, driven by declines in Consumer Lifestyle and Lighting. EBITA margins improved due to cost reductions.
- Healthcare sales grew 1% in Q3, with double-digit growth in emerging markets offsetting declines in the US. Emerging markets now represent 42% of Healthcare sales.
- Emerging markets sales declined 11% in Q3 but grew 11% over the last twelve months, reflecting Philips' strategic focus on expanding in these high-growth regions.
HP reported financial results for the third quarter of fiscal year 2009. Revenue declined 2% year-over-year to $27.5 billion but was up 4% excluding currency effects. Non-GAAP earnings per share increased 6% to $0.91. Cash flow from operations was strong at $3.9 billion, up 15% over the prior year. The company saw increased stability in the US market and double-digit growth in China. Integration of the EDS acquisition is ahead of plan and expected to realize significant cost synergies. HP will continue investing in strategic growth areas like data centers, digital printing, and mobility.
Adobe announced it will acquire Omniture for $1.8 billion to combine Adobe's content creation tools with Omniture's analytics and optimization technologies. The acquisition will allow customers to optimize content engagement and advertising effectiveness across digital platforms. Omniture will become a new business unit within Adobe led by its current CEO. The deal is expected to close in the fourth quarter of 2009 and be accretive to Adobe's earnings in 2010.
IBM's strategy focuses on shifting to higher value segments of the IT industry through global integration, productivity improvements, and investing in growth markets and technologies. This transformation has driven margin expansion and allowed IBM to invest in the future while providing returns to shareholders. IBM is well ahead of its goal to achieve $10-11 EPS by 2010 through revenue growth, continued margin gains, and share repurchases. The company will focus on growth markets, acquisitions, technology leadership, and new initiatives to sustain long-term performance.
Abbott: 2009 Annual Shareholders Meeting Remarks And Presentationsinvestorrelation
Miles White, Chairman and CEO of Abbott, presented at the company's annual shareholders meeting. He summarized Abbott's strong financial performance in 2008, with double-digit sales and earnings growth despite economic challenges. Abbott experienced growth across all major businesses - medical devices, nutrition, diagnostics, and pharmaceuticals. White highlighted several new product launches that contributed to growth and discussed Abbott's leadership positions in various health care markets. He expressed confidence in Abbott's ability to meet financial goals for 2009 and emphasized the company's diversity and strength compared to peers in withstanding economic downturns.
Exxon Mobil Corporation at Barclays Capital 2009 CEO Energy Conferenceinvestorrelation
This document provides an overview of ExxonMobil's business model and strategy for delivering value through economic cycles. It discusses ExxonMobil's focus on risk management, financial strength, asset quality and diversity, and disciplined operations. Charts show ExxonMobil's consistent reserves replacement, lower cost reserves additions, project execution excellence, and industry-leading upstream volumes, earnings, and returns. The document outlines ExxonMobil's significant global project portfolio and future capacity growth.
1. Bayer's Q2 2009 results showed strong performance in HealthCare, CropScience at last year's levels, and stabilization in MaterialScience. Restructuring at MaterialScience including first plant closures was accelerated.
2. Key figures show sales of €8 billion, a 9% decline in underlying EBITDA, and a 12% decline in core EPS. HealthCare grew 8% in sales and 15% in underlying EBITDA. CropScience grew 3% in sales and was flat in underlying EBITDA. MaterialScience sales declined 30% and underlying EBITDA declined 67%.
3. Bayer reaffirmed its outlook of limiting the decline in underlying Group EBITDA to approximately
"Oracle Insight for Investors" Educational Webcast - Oracle Fusion Middlewareinvestorrelation
The document discusses Oracle's new Fusion Middleware 11g product. It highlights new features in areas like developer tools, service-oriented architecture, enterprise portals, application grids, identity management, and business intelligence. It also discusses Oracle Fusion Middleware's leadership position in middleware based on various analyst reports and customer satisfaction surveys. The document promotes Oracle Fusion Middleware 11g's integrated development environment, performance improvements, and adoption by industry leaders.
- IBM's 2Q'09 results showed strong performance with improved operating leverage, expanded gross margins, 18% EPS growth, and $4.5B in free cash flow.
- For FY'09, IBM expects EPS of at least $9.70, ahead of its 2010 roadmap target of $10-11 EPS.
- IBM's business segments - Software, Services, and Systems & Technology - saw revenue changes between -10% to +11% in 2008, with goals for long-term pre-tax income growth between 7-15% depending on the segment.
Chevron at Barclays Capital 2009 CEO Energy/Power Conferenceinvestorrelation
Pat Yarrington, CFO of Chevron Corporation, presented at the 2009 Barclays Capital CEO Energy/Power Conference in New York City on September 9, 2009. He discussed Chevron's strategic advantages including its leading exploration performance, top portfolio of projects, strong project execution track record, and engineering and technology leadership. Yarrington also highlighted Chevron's financial strength and focus on cost reduction during the current economic environment.
Intel reported financial results for 2008 with revenue of $37.6 billion, down 2% from 2007. Net income was $5.3 billion, down 24% from the prior year. Intel generated $10.9 billion in cash from operations and paid $3.1 billion in dividends. Paul Otellini, Intel's President and CEO, stated that Intel's product portfolio and technology roadmap are strong and will help the company thrive when the economy recovers. Craig Barrett, Intel's Chairman, discussed Intel's role in global initiatives that apply technology to address challenges in areas such as healthcare, education, and sustainability.
WNS is a leading global business process outsourcing company with over 21,000 employees. It provides business process outsourcing services to over 215 global clients across multiple industries such as banking, insurance, travel, utilities and retail. WNS utilizes its deep industry expertise, comprehensive service offerings and proven track record to deliver operational excellence and business value to its clients.
- UBS reported adjusted pre-tax profits of CHF 1 billion for the second quarter of 2009, an improvement from the prior quarter.
- The company strengthened its Tier 1 capital ratio to 13.7% and increased its FINMA leverage ratio to 3.5% through actions like reducing risk exposures and balance sheet size.
- UBS continued reducing costs and is on track to reach its target of less than CHF 20 billion in annualized fixed costs.
UBS reported on its capital management and liquidity position in the second quarter of 2009. Key points include:
- UBS strengthened its capital ratios, with the Tier 1 ratio increasing to 13.2% and BIS total ratio to 17.7% due to a capital increase and lower risk-weighted assets.
- Risk-weighted assets were reduced by CHF 30 billion during the quarter through asset reductions in the Investment Bank, Wealth Management & Swiss Bank, and Wealth Management Americas divisions.
- UBS issued long-term debt totaling over CHF 10 billion to increase its funding sources while continuing to reduce its balance sheet.
The document is a presentation by BMW Group providing an overview and update on their business and strategy:
1) In the first half of 2009, BMW Group saw revenues decrease 12.1% and profit before tax turn to a loss of €47 million compared to a profit of €1,243 million in the same period in 2008 due to the economic downturn.
2) BMW Group outlined actions for 2009 such as cost reductions, optimization of capital employed, and strict cash flow management to address the challenging market conditions.
3) BMW Group's long-term "Number ONE" strategy aims to make the company the leading provider of premium products and services for mobility by 2020, including targets to increase profitability and
Morgan Stanley: Barclays Financial Services Conferenceinvestorrelation
Morgan Stanley's Co-President James Gorman and CFO Colm Kelleher presented at the Barclays Financial Services Conference. They discussed Morgan Stanley's strategic priorities which include optimizing Institutional Securities, successfully integrating the Morgan Stanley Smith Barney joint venture, restructuring Asset Management, and developing a strategic alliance with MUFG. They provided an update on the integration of Morgan Stanley Smith Barney, noting that cost synergies exceeded $1.1 billion and revenue synergies were $275 million. Gorman stated that Morgan Stanley Smith Barney is positioned to achieve industry-leading margins of over 20% by 2011.
Johnson & Johnson: Pharmaceutical Business Reviewinvestorrelation
The document discusses Johnson & Johnson's pharmaceutical business and strategies for growth. It notes that J&J is the 7th largest pharmaceutical company globally with $24.6 billion in pharmaceutical sales in 2008. It outlines J&J's strategies to grow its core business globally, successfully execute new product launches, build a robust pipeline, fuel growth in emerging markets, shape the external environment, and focus on its people. The document also provides an overview of the global pharmaceutical market and key dynamics.
This document contains the transcript of a presentation discussing PayPal's business. It states that the presentation may contain forward-looking statements about Q3 2009 performance and future growth that involve risks and uncertainties. Actual results could differ for various reasons, including global economic conditions, foreign exchange rates, acquisitions, divestitures, competition, managing a large diverse business, regulatory risks, technology upgrades, and litigation risks. More information on risk factors is in eBay's annual and quarterly SEC filings. All information is as of July 22, 2009.
This document is the second quarter and year-to-date results report from The Coca-Cola Company. Some key points:
- Unit case volume grew 4% in the quarter and 3% year-to-date, driving global gains in volume and value share.
- Operating income was down 9% for the quarter and 6% year-to-date, but comparable currency neutral operating income grew 4% and 9% respectively.
- EPS grew 44% for the quarter to $0.88, but comparable EPS fell 9% to $0.92 due to currency impacts. Productivity initiatives remain on track to achieve $500M in annual savings by 2011.
Ford reported its second quarter 2009 earnings. While wholesale sales and revenue declined compared to the second quarter of 2008, Ford reduced structural costs and improved pre-tax operating results. Ford gained market share in key regions and launched new products. Ford also took actions to reduce debt and raised capital through a stock offering to strengthen its financial position.
- GM reported preliminary first quarter 2007 results with GAAP EPS of $0.11 and adjusted EPS of $0.17.
- Adjusted total automotive results improved $0.3 billion versus Q1 2006 driven by improved results at GMNA, GMLAAM, and GMAP.
- GMAC reported a net loss of $115 million compared to net income of $495 million in Q1 2006 due to continued weakness in its mortgage business.
GM reported preliminary second quarter 2007 results with adjusted EPS of $2.48. Key highlights included record automotive revenue, continued share gains outside North America, and adjusted automotive operating cash flow of $1.1 billion. GM also announced the planned sale of Allison Transmission for $5.6 billion. While results improved from the second quarter of 2006, they included special items such as $374 million related to Delphi. GM maintained a strong liquidity position of $27.2 billion.
- GM reported a GAAP net loss of $38.9 billion for Q3 2007 due to a $38.6 billion non-cash charge for establishing a valuation allowance against deferred tax assets in the US, Canada and Germany. Excluding special items, the adjusted net loss was $1.6 billion.
- Automotive revenue was a record $43.1 billion for Q3, while adjusted automotive results improved $577 million versus Q3 2006. GMAC reported a loss of $757 million due entirely to losses at ResCap related to the challenging US housing market.
- GM's gross liquidity increased to $30 billion at the end of the quarter, including $5.4 billion in proceeds
GM's preliminary 2007 fourth quarter results showed:
- A GAAP net loss of $0.7 billion compared to an adjusted net income of $46 million, excluding special items.
- Total automotive revenue reached an all-time record of $46.7 billion.
- Adjusted automotive operating cash flow was negative $1.3 billion.
- GMNA's adjusted EBT declined by $0.9 billion from the fourth quarter of 2006 due to lower volume, mix, and pricing partially offset by manufacturing performance.
Exxon Mobil Corporation at Barclays Capital 2009 CEO Energy Conferenceinvestorrelation
This document provides an overview of ExxonMobil's business model and strategy for delivering value through economic cycles. It discusses ExxonMobil's focus on risk management, financial strength, asset quality and diversity, and disciplined operations. Charts show ExxonMobil's consistent reserves replacement, lower cost reserves additions, project execution excellence, and industry-leading upstream volumes, earnings, and returns. The document outlines ExxonMobil's significant global project portfolio and future capacity growth.
1. Bayer's Q2 2009 results showed strong performance in HealthCare, CropScience at last year's levels, and stabilization in MaterialScience. Restructuring at MaterialScience including first plant closures was accelerated.
2. Key figures show sales of €8 billion, a 9% decline in underlying EBITDA, and a 12% decline in core EPS. HealthCare grew 8% in sales and 15% in underlying EBITDA. CropScience grew 3% in sales and was flat in underlying EBITDA. MaterialScience sales declined 30% and underlying EBITDA declined 67%.
3. Bayer reaffirmed its outlook of limiting the decline in underlying Group EBITDA to approximately
"Oracle Insight for Investors" Educational Webcast - Oracle Fusion Middlewareinvestorrelation
The document discusses Oracle's new Fusion Middleware 11g product. It highlights new features in areas like developer tools, service-oriented architecture, enterprise portals, application grids, identity management, and business intelligence. It also discusses Oracle Fusion Middleware's leadership position in middleware based on various analyst reports and customer satisfaction surveys. The document promotes Oracle Fusion Middleware 11g's integrated development environment, performance improvements, and adoption by industry leaders.
- IBM's 2Q'09 results showed strong performance with improved operating leverage, expanded gross margins, 18% EPS growth, and $4.5B in free cash flow.
- For FY'09, IBM expects EPS of at least $9.70, ahead of its 2010 roadmap target of $10-11 EPS.
- IBM's business segments - Software, Services, and Systems & Technology - saw revenue changes between -10% to +11% in 2008, with goals for long-term pre-tax income growth between 7-15% depending on the segment.
Chevron at Barclays Capital 2009 CEO Energy/Power Conferenceinvestorrelation
Pat Yarrington, CFO of Chevron Corporation, presented at the 2009 Barclays Capital CEO Energy/Power Conference in New York City on September 9, 2009. He discussed Chevron's strategic advantages including its leading exploration performance, top portfolio of projects, strong project execution track record, and engineering and technology leadership. Yarrington also highlighted Chevron's financial strength and focus on cost reduction during the current economic environment.
Intel reported financial results for 2008 with revenue of $37.6 billion, down 2% from 2007. Net income was $5.3 billion, down 24% from the prior year. Intel generated $10.9 billion in cash from operations and paid $3.1 billion in dividends. Paul Otellini, Intel's President and CEO, stated that Intel's product portfolio and technology roadmap are strong and will help the company thrive when the economy recovers. Craig Barrett, Intel's Chairman, discussed Intel's role in global initiatives that apply technology to address challenges in areas such as healthcare, education, and sustainability.
WNS is a leading global business process outsourcing company with over 21,000 employees. It provides business process outsourcing services to over 215 global clients across multiple industries such as banking, insurance, travel, utilities and retail. WNS utilizes its deep industry expertise, comprehensive service offerings and proven track record to deliver operational excellence and business value to its clients.
- UBS reported adjusted pre-tax profits of CHF 1 billion for the second quarter of 2009, an improvement from the prior quarter.
- The company strengthened its Tier 1 capital ratio to 13.7% and increased its FINMA leverage ratio to 3.5% through actions like reducing risk exposures and balance sheet size.
- UBS continued reducing costs and is on track to reach its target of less than CHF 20 billion in annualized fixed costs.
UBS reported on its capital management and liquidity position in the second quarter of 2009. Key points include:
- UBS strengthened its capital ratios, with the Tier 1 ratio increasing to 13.2% and BIS total ratio to 17.7% due to a capital increase and lower risk-weighted assets.
- Risk-weighted assets were reduced by CHF 30 billion during the quarter through asset reductions in the Investment Bank, Wealth Management & Swiss Bank, and Wealth Management Americas divisions.
- UBS issued long-term debt totaling over CHF 10 billion to increase its funding sources while continuing to reduce its balance sheet.
The document is a presentation by BMW Group providing an overview and update on their business and strategy:
1) In the first half of 2009, BMW Group saw revenues decrease 12.1% and profit before tax turn to a loss of €47 million compared to a profit of €1,243 million in the same period in 2008 due to the economic downturn.
2) BMW Group outlined actions for 2009 such as cost reductions, optimization of capital employed, and strict cash flow management to address the challenging market conditions.
3) BMW Group's long-term "Number ONE" strategy aims to make the company the leading provider of premium products and services for mobility by 2020, including targets to increase profitability and
Morgan Stanley: Barclays Financial Services Conferenceinvestorrelation
Morgan Stanley's Co-President James Gorman and CFO Colm Kelleher presented at the Barclays Financial Services Conference. They discussed Morgan Stanley's strategic priorities which include optimizing Institutional Securities, successfully integrating the Morgan Stanley Smith Barney joint venture, restructuring Asset Management, and developing a strategic alliance with MUFG. They provided an update on the integration of Morgan Stanley Smith Barney, noting that cost synergies exceeded $1.1 billion and revenue synergies were $275 million. Gorman stated that Morgan Stanley Smith Barney is positioned to achieve industry-leading margins of over 20% by 2011.
Johnson & Johnson: Pharmaceutical Business Reviewinvestorrelation
The document discusses Johnson & Johnson's pharmaceutical business and strategies for growth. It notes that J&J is the 7th largest pharmaceutical company globally with $24.6 billion in pharmaceutical sales in 2008. It outlines J&J's strategies to grow its core business globally, successfully execute new product launches, build a robust pipeline, fuel growth in emerging markets, shape the external environment, and focus on its people. The document also provides an overview of the global pharmaceutical market and key dynamics.
This document contains the transcript of a presentation discussing PayPal's business. It states that the presentation may contain forward-looking statements about Q3 2009 performance and future growth that involve risks and uncertainties. Actual results could differ for various reasons, including global economic conditions, foreign exchange rates, acquisitions, divestitures, competition, managing a large diverse business, regulatory risks, technology upgrades, and litigation risks. More information on risk factors is in eBay's annual and quarterly SEC filings. All information is as of July 22, 2009.
This document is the second quarter and year-to-date results report from The Coca-Cola Company. Some key points:
- Unit case volume grew 4% in the quarter and 3% year-to-date, driving global gains in volume and value share.
- Operating income was down 9% for the quarter and 6% year-to-date, but comparable currency neutral operating income grew 4% and 9% respectively.
- EPS grew 44% for the quarter to $0.88, but comparable EPS fell 9% to $0.92 due to currency impacts. Productivity initiatives remain on track to achieve $500M in annual savings by 2011.
Ford reported its second quarter 2009 earnings. While wholesale sales and revenue declined compared to the second quarter of 2008, Ford reduced structural costs and improved pre-tax operating results. Ford gained market share in key regions and launched new products. Ford also took actions to reduce debt and raised capital through a stock offering to strengthen its financial position.
- GM reported preliminary first quarter 2007 results with GAAP EPS of $0.11 and adjusted EPS of $0.17.
- Adjusted total automotive results improved $0.3 billion versus Q1 2006 driven by improved results at GMNA, GMLAAM, and GMAP.
- GMAC reported a net loss of $115 million compared to net income of $495 million in Q1 2006 due to continued weakness in its mortgage business.
GM reported preliminary second quarter 2007 results with adjusted EPS of $2.48. Key highlights included record automotive revenue, continued share gains outside North America, and adjusted automotive operating cash flow of $1.1 billion. GM also announced the planned sale of Allison Transmission for $5.6 billion. While results improved from the second quarter of 2006, they included special items such as $374 million related to Delphi. GM maintained a strong liquidity position of $27.2 billion.
- GM reported a GAAP net loss of $38.9 billion for Q3 2007 due to a $38.6 billion non-cash charge for establishing a valuation allowance against deferred tax assets in the US, Canada and Germany. Excluding special items, the adjusted net loss was $1.6 billion.
- Automotive revenue was a record $43.1 billion for Q3, while adjusted automotive results improved $577 million versus Q3 2006. GMAC reported a loss of $757 million due entirely to losses at ResCap related to the challenging US housing market.
- GM's gross liquidity increased to $30 billion at the end of the quarter, including $5.4 billion in proceeds
GM's preliminary 2007 fourth quarter results showed:
- A GAAP net loss of $0.7 billion compared to an adjusted net income of $46 million, excluding special items.
- Total automotive revenue reached an all-time record of $46.7 billion.
- Adjusted automotive operating cash flow was negative $1.3 billion.
- GMNA's adjusted EBT declined by $0.9 billion from the fourth quarter of 2006 due to lower volume, mix, and pricing partially offset by manufacturing performance.